Hepatocyte Growth Factor
For the measurement of human HGF in human serum
Serum Hepatocyte growth factor level elevates in various liver diseases and fluctuates reflecting the conditions of patients. Serum HGF concentration in fulminant hepatitis patients increases significantly in comparison with those in other hepatitis and its close relation with encephalopathy is known widely. That is, this marker shows an abnormal elevation just before expression of encephalopathy and decreases with recovery from it. After expression of encephalopathy, HGF level further elevates when poor prognosis is expected. Since prothrombin time as one of the diagnostic criteria of fulminant hepatitis also decreases in acute hepatitis, liver cirrhosis, or hepatocellular carcinoma, HGF is expected to be a marker more specific to fulminant hepatitis. Determination of HGF, therefore, is an effective means for diagnosis of fulminant hepatitis at its early stage and its prognosis. This kit affords determination of serum HGF at ease by means of the enzyme linked immunosorbant assay using monoclonal antibodies.
human Hepatocyte Growth Factor ELISA
|Colorimetric (EIA) Kits||Catalogue Number|
|96 well plate||K2001-1|
Determination range is 0.1 ng/mL is the lowest limit and 3.0 ng/mL is the highest limit of the calibration curve. Samples of higher HGF concentration than this must be diluted in advance with the sample diluent.
FOR RESEARCH USE ONLY - NOT FOR USE IN DIAGNOSTIC PROCEDURES
Diagnostics Ltd. 29 Forest Road, Piddington, Northampton. NN7 2DA.
Tel. (01604) 870370 Fax (01604) 870194